Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1988-10-18
|
pubmed:abstractText |
This prospective study was designed to evaluate the effects on glucose metabolism of terbutaline used as an oral tocolytic agent. Eighty-six patients were studied when admitted for preterm labor from 24 to 35 weeks' gestation. After intravenous tocolysis, these patients were maintained on 5 mg of terbutaline every 4 or 6 hours. An oral 50 gm, 1-hour glucose challenge test was done 48 hours after terbutaline dosing began. All abnormal glucose challenge test results (greater than or equal to 135 mg/dl) were followed by a standard 100 gm oral glucose tolerance test. Sixty-three percent (54 of 86) of the terbutaline group had an abnormal 1-hour screening result, which was significantly different than the 26.7% (23 of 86) observed in the control group (p less than 0.001). The mean fasting blood sugar and 1-hour postchallenge values were significantly higher in the study than in the control group (p less than 0.0001). Ten of 86 in the treated group (11.6%) and 2 of 86 in the control group (2.3%) with abnormal results met the criteria for gestational diabetes. These numbers achieve statistical significance at p less than 0.05. This study shows a significant effect of oral terbutaline therapy on glucose tolerance during pregnancy. Patients receiving oral terbutaline therapy for suppression of preterm labor should undergo screening for gestational diabetes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Betamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Magnesium Sulfate,
http://linkedlifedata.com/resource/pubmed/chemical/Ritodrine,
http://linkedlifedata.com/resource/pubmed/chemical/Terbutaline
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0002-9378
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
159
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
762-6
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3421277-Adult,
pubmed-meshheading:3421277-Betamethasone,
pubmed-meshheading:3421277-Blood Glucose,
pubmed-meshheading:3421277-Female,
pubmed-meshheading:3421277-Glucose Tolerance Test,
pubmed-meshheading:3421277-Humans,
pubmed-meshheading:3421277-Magnesium Sulfate,
pubmed-meshheading:3421277-Obstetric Labor, Premature,
pubmed-meshheading:3421277-Pregnancy,
pubmed-meshheading:3421277-Pregnancy in Diabetics,
pubmed-meshheading:3421277-Prospective Studies,
pubmed-meshheading:3421277-Ritodrine,
pubmed-meshheading:3421277-Terbutaline
|
pubmed:year |
1988
|
pubmed:articleTitle |
Carbohydrate intolerance in patients receiving oral tocolytics.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of South Florida College of Medicine, Tampa.
|
pubmed:publicationType |
Journal Article
|